Trulieve Cannabis
- Market cap
- 2.08B
- P/E (TTM)i
- -4.36
- P/Bi
- 2.71
- EPSi
- -0.61
- Div yieldi
- 0.00%
- 52W posi
- 71%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Trulieve Cannabis closed at 10.78, up 1.22%. Its market capitalisation is about 2.08B, the #2769 most valuable US-listed company we track. The trailing P/E of -4.31 is 300% below its five-year average of 2.16. Wall Street's 4-analyst consensus lands on Buy, with a price target averaging 17.81 (+65% from here). The shares sit 71% of the way up their 52-week range of 4.62 to 13.28.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 day.
- Recent price momentum is +21.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 2.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth C+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | -1.0% | Better than 18% |
| Net income CAGR (3Y) | 18.3% | Better than 72% |
Profitability C-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 60.2% | Better than 75% |
| Operating margin | 12.6% | Better than 42% |
| Net margin | -9.9% | Better than 6% |
| Return on equity | -9.6% | Better than 9% |
| Return on invested capital | -4.1% | Better than 10% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 19.3% | Better than 87% |
| 6-month return | 76.9% | Better than 94% |
| 12-month return (ex latest month) | 36.8% | Better than 72% |
| Distance below 52-week high | 19.8% | Better than 47% |
Financial Health B+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.4x | Better than 91% |
| Debt to assets | 20.9% | Better than 63% |
| Interest coverage | 2.4x | Better than 23% |
Analyst View A
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 80% |
| Upside to average target | 67.2% | Better than 90% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 10.65
- Open
- 10.70
- Day range
- 10.55 - 10.92
- Avg price
- 10.78
- Volume
- 2.01M
- Turnover
- 21.68M
- Turnover ratei
- 1.39%
- Volume ratioi
- 0.62
- Amplitudei
- 3.47%
- 52-week rangei
- 4.62 - 13.28
Valuation
- P/Ei
- -17.67
- P/E (TTM)i
- -4.36
- P/Bi
- 2.71
- EPSi
- -0.61
- Book value / shi
- 3.99
- Net profit
- -117.46M
- Net assets
- 767.37M
Share structure
- Market cap
- 2.08B
- Float capi
- 1.57B
- Shares out
- 192.57M
- Float sharesi
- 145.20M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
18.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-3.47M net over the window
Short interest
- Shares short
- 5.12M
- % of floati
- 2.66%
- Days to coveri
- 2.84
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Trulieve Cannabis (TRLV)?
Trulieve Cannabis last traded at 10.78. The quote on this page refreshes every few seconds while US markets are open.
What is Trulieve Cannabis's market cap?
About 2.08B.
What is the P/E ratio of Trulieve Cannabis?
The trailing twelve-month P/E is -4.36, below its own 5-year average of 2.16 — in the middle of its historical range (42.75% percentile). See the Valuation tab for the full history.
Does Trulieve Cannabis pay a dividend?
Trulieve Cannabis does not currently pay a regular dividend.
Is Trulieve Cannabis a buy according to analysts?
The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 17.81, which implies 65.2% upside from the current price. This is not investment advice.
What is Trulieve Cannabis's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Trulieve Cannabis a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-07 20:02:23 · For reference only, not investment advice and not tailored to your situation.